Sagent Pharmaceuticals Announces the Launch of Vancomycin Hydrochloride for Injection, USP

[at noodls] – SCHAUMBURG, Ill., Sept. 28, 2012 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Vancomycin Hydrochloride for Injection, USP, an anti-infective, in a 5 gram … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard